Prophylactic efficacy of Ivermectin is estimated to be 96%, higher than Pfizer and Moderna vaccines efficacies of 95% and 94%, respectively

massimaux | 1 points | Dec 21 2020 20:27:43

Prophylactic efficacy of Ivermectin is estimated to be 96%, higher than Pfizer and Moderna vaccines efficacies of 95% and 94%, respectively

|^(Author, Country, Source)|^(IVM arm)|^(Non-IVM arm)|^(No. of infected in IVM arm)|^(No. of infected in non-IVM arm)|^(Risk Ratio (%))|^(Prophylactic Efficacy (%))|^(p-value)| |:-|:-|:-|:-|:-|:-|:-|:-| |^(Shouman W, Egypt) ^(ClinicalTrials.gov)|^(203)|^(101)|^(15)|^(59)|^(12.6)|^(87.4)|^(<0.001)| |^(Carvallo H, Argentina) ^(Journal of Bioch. Research and Investigation)|^(788)|^(407)|^(0)|^(237)|^(0)|^(100)|^(<0.001)| |^(Elgazzar A, Egypt) ^(ResearchSquare)|^(100)|^(100)|^(2)|^(20)|^(20)|^(80)|^(0.03)| |^(Alam MT. Bangladesh) ^(European J Med Hlth Sciences)|^(58)|^(60)|^(4)|^(44)|^(9.4)|^(90.6)|^(<0.001)| |^(Aggregated)|^(1149)|^(668)|^(21)|^(350)|^(3.5)|^(96.5)|^(<0.001)|

[-] massimaux | 1 points | Dec 21 2020 20:29:36

|Author, Country, Source|IVM arm|Non-IVM arm|No. of infected in IVM arm|No. of infected in non-IVM arm|Risk Ratio (%)|Prophylactic Efficacy (%)|p-value| |:-|:-|:-|:-|:-|:-|:-|:-| |Shouman W, Egypt ClinicalTrials.gov|203|101|15|59|12.6|87.4|<0.001| |Carvallo H, Argentina Journal of Bioch. Research and Investigation|788|407|0|237|0|100|<0.001| |Elgazzar A, Egypt ResearchSquare|100|100|2|20|20|80|0.03| |Alam MT. Bangladesh European J Med Hlth Sciences|58|60|4|44|9.4|90.6|<0.001| |Aggregated|1149|668|21|350|3.5|96.5|<0.001|